Genomic Profiling of Advanced Pancreatic Cancer to inform therapy - RNA-Seq mapped reads
Genomics-Driven Precision Medicine for Advanced Pancreatic Cancer - Early Results from the COMPASS Trial - RNA-Seq mapped reads
- 18/09/2017
- DAC: EGAC00001000710
OICR Data Access Agreement v2.0. Link to Policy Url here
OICR-DAC manages genomic and transcriptomic data sets generated at the Ontario Institute for Cancer Research 1. To access data, you must complete the OICR Data Access Agreement (DAA, see Policy Url above). Fields in red are mandatory. 2. The DAA should include the name(s) of all investigators who will download and/or analyze data. 3. All investigators must be from the same institution, and institutional email addresses must be used. 4. The DAA must be signed by an institutional signatory who has authority to bind the corporation. 5. Once completed, forward to OICR-DAC@oicr.on.ca for review. Data access will be granted upon final execution of the agreement. Note: To access and download data, each investigator must submit a “Request Access” form on the EGA website. A separate DAA is not required if they are already named on a fully executed DAA (as per above).
Studies are experimental investigations of a particular phenomenon, e.g., case-control studies on a particular trait or cancer research projects reporting matching cancer normal genomes from patients.
| Study ID | Study Title | Study Type |
|---|---|---|
| EGAS00001002543 | Other |
This table displays only public information pertaining to the files in the dataset. If you wish to access this dataset, please submit a request. If you already have access to these data files, please consult the download documentation.